TP53 and cancer: It was demonstrated that wild-type p53 was able to inhibit cancer cell invasion by suppressing NF-κB-mediated activation of Fascin, whereas, p53 deletion triggered NF-κB-mediated activation of Fascin, thereby augmenting cancer cell invasion and metastasis.